We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current PRTA market cap is 707.29M. The company's latest EPS is USD -2.2723 and P/E is -5.78.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 316k | 50k | 132.01M | 970k | 2.12M |
| Operating Income | -47.96M | -81.53M | 58.38M | -66.71M | -39.27M |
| Net Income | -67.48M | -72.24M | 66.89M | -59M | -57.96M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 853k | 200.58M | 53.91M | 91.37M | 135.16M |
| Operating Income | -112.73M | 71.98M | -131.56M | -191.04M | -128.93M |
| Net Income | -111.14M | 66.98M | -116.95M | -147.03M | -122.31M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 696.38M | 623.19M | 645.57M | 595.25M | 547.11M |
| Total Liabilities | 135.02M | 120.8M | 63.65M | 60.89M | 60.18M |
| Total Equity | 561.37M | 502.4M | 581.92M | 534.36M | 486.93M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 332.98M | 609.37M | 758.04M | 696.38M | 547.11M |
| Total Liabilities | 148.97M | 143.32M | 135.99M | 135.02M | 60.18M |
| Total Equity | 184.01M | 466.04M | 622.04M | 561.37M | 486.93M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | N/A | -73.05M | -57.09M | -102.28M | N/A |
| Investing | N/A | -103k | -246k | -255k | N/A |
| Financing | N/A | 836k | 1.28M | 1.61M | N/A |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -80.36M | 92.61M | -108.82M | -133.91M | N/A |
| Investing | -196k | -575k | -464k | -2.77M | N/A |
| Financing | 215k | 190.33M | 241.46M | 45.1M | N/A |
| Market Cap | 707.29M |
| Price to Earnings Ratio | -5.78 |
| Price to Sales Ratio | 5.23 |
| Price to Cash Ratio | 1.5 |
| Price to Book Ratio | 1.45 |
| Dividend Yield | - |
| Shares Outstanding | 53.83M |
| Average Volume (1 week) | 501.35k |
| Average Volume (1 Month) | 460.2k |
| 52 Week Change | -47.96% |
| 52 Week High | 26.36 |
| 52 Week Low | 11.70 |
| Spread (Intraday) | 1.12 (8.13%) |
| Company Name | Prothena Corporation PLC |
| Address |
77 sir john rogerson’s quay dublin D02 VK60 |
| Website | https://www.prothena.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
